Global Poultry Vaccines Market to Reach US$ 3.2 Billion by 2032, Bolstered by Growing Awareness Among Veterinary Practitioners

May 26, 2022 | Healthcare

The latest report by IMARC Group, titled “Poultry Vaccines Market Report by Disease (Infectious Bronchitis, Avian Influenza, Newcastle Disease, Marek's Disease, and Others), Product (Recombinant Vaccine, Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, and Others), Dosage Form (Liquid Vaccine, Freeze Dried Vaccine), Application (Breeder, Broiler, Layer), End User (Veterinary Hospitals, Poultry Firm, Poultry Vaccination Center), and Region 2024-2032,” finds that the global poultry vaccines market size reached US$ 1.9 Billion in 2023. Poultry vaccines help prevent any disease that infects the immune system of bird species, including duck, chicken, turkey, and goose. They produce antibodies that fight against organisms, such as Salmonella, E. Coli, and Mycoplasma gallisepticum (MG), and diseases such as Marek’s disease, infectious bronchitis (IB), avian rhinotracheitis (ART), Newcastle disease and infectious bursal disease (Gumboro disease). Poultry vaccines vary from mild to severe in their dosage, which is approved, only if they pass the World Organization for Animal Health standards. They are administered via various routes such as nasal, oral, subcutaneous ocular and in-vivo intramuscular. Poultry vaccines are applied to different areas of the egg, such as the body of the embryo, allantois sac, yolk sac, and amniotic fluid.

Global Poultry Vaccines Market Trends: 

The market is primarily driven by the rising awareness regarding animal vaccination among veterinary practitioners and increasing prevalence of zoonotic diseases. Diseases, such as bird flu or avian influenza, are also known to infect humans and animals. Besides this, the escalating demand for animal health diagnostics also represents a major factor contributing to the market growth. In addition, the growing consumption of meat and poultry-related food products is facilitating extensive expenditure on poultry healthcare. Along with this, governmental bodies across the globe are taking initiatives to educate people regarding the benefits of poultry vaccines, thus accelerating the product adoption rate. Furthermore, growing research and development (R&D) activities to develop advanced technologies to manufacture effective vaccines are creating a positive outlook for the market. For instance, there has been an introduction of live, non-replicating recombinant antigens, nucleic acid-mediated, and live-gene detected vaccines. On account of these factors, the market value is expected to reach US$ 3.2 Billion by 2032, exhibiting a CAGR of 5.6% during the forecast period (2024-2032).

Market Summary: 

  • Based on the disease, the market has been segmented into infectious bronchitis, avian influenza, Newcastle disease, Marek’s disease, and others.
  • On the basis of the product, the market has been classified into recombinant, live attenuated, inactivated, subunit, and other vaccines.
  • The market has been bifurcated based on the dosage form into liquid and freeze-dried vaccines.
  • Based on the application, the market has been categorized into breeder, broiler and layer.
  • On the basis of the end user, the market has been segregated into veterinary hospitals, poultry firm, and poultry vaccination center.
  • Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has been examined, with some of the key players being AniCon Labor GmbH (SAN Group), Biovac Limited, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Elanco, Hester Biosciences Limited, Merck & Co. Inc., Phibro Animal Health Corporation, Venkys India, and Zoetis Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Disease, Product, Dosage Form, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AniCon Labor GmbH (SAN Group), Biovac Ltd., Boehringer Ingelheim International GmbH, Ceva Santé Animale, Elanco, Hester Biosciences Limited, Merck & Co. Inc., Phibro Animal Health Corporation, Venkys India and Zoetis Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Poultry Vaccines Market to Reach US$ 3.2 Billion by 2032, Bolstered by Growing Awareness Among Veterinary Practitioners
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More